News
Pharmaceutical Technology on MSN3d
Padcev-Keytruda combo approved for NHS use in mUC
The combination will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback